Is Neratinib included in medical insurance?

Neratinib (Neratinib)is an anti-tumor agent and is a potent, selective and irreversible inhibitor of human epidermal growth factor receptor type 2 (HER2), HER4 and epidermal growth factor receptor (EGFR) tyrosine kinases. The original drug of neratinib is marketed in China as neratinib maleate tablets and is covered by Class B medical insurance. However, reimbursement is limited to patients who meet the indications, including applicable to intensive adjuvant treatment of adult patients with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer after receiving adjuvant therapy containing trastuzumab. SpecificationsThe price of each box of 40mg*180 tablets may be around RMB 7,000. The reimbursement ratio is different in different regions. The price after reimbursement may be different. Please consult the local medical insurance bureau or hospital for details.